Also

* Pfizer Inc. will pay $1.3 billion to Sanofi-Aventis Group to obtain full worldwide rights to the inhaled insulin the companies developed jointly and were planning to co-market. In September, a Food and Drug Administration panel voted to recommend inhaled insulin for approval but extended its review of the medication, Exhubera.

* Northwest Airlines Corp. pilots voted overwhelmingly to approve a freeze in their pensions as the company shifted to a plan based on employee contributions, their union said.